Scientist 1
Nanovation Therapeutics
Scientist 1
Nanovation Therapeutics
Develops lipid nanoparticle nucleic acid therapies
About NanoVation Therapeutics
NanoVation Therapeutics is a Vancouver-based biotechnology company developing long-circulating lipid nanoparticle (lcLNP™) technology for genetic medicines. Founded on proprietary lipid chemistry and LNP engineering expertise, NanoVation’s platform enables functional delivery to extrahepatic tissues including immune cells, bone marrow, and tumors, without the need for targeting ligands. The company partners with pharmaceutical and biotech organizations to advance mRNA, DNA, and gene editing programs that require delivery beyond the liver.
We are building our team and looking for highly motivated individuals seeking to use their knowledge to revolutionize the healthcare of tomorrow. For more information, please visit nanovationtx.com.
Position Summary
NanoVation Therapeutics is seeking a Scientist I, Preclinical to join our team for a 12-month contract. This role is ideal for a strong and collaborative communicator who thrives in a fast-paced research environment.
Reporting to the Senior Scientist II, Preclinical - Team Lead, our Scientist, I Preclinical will be responsible for designing, executing, analyzing, and making recommendations on preclinical research to advance our research projects.
The successful candidate will bring:
This is an exciting opportunity to contribute to cutting-edge research and help shape the future of our preclinical pipeline.
Responsibilities include, but are not limited to:
Preclinical Research
Project Teamwork
Innovation
Mentors and Supervises Team Members
Education & Experience Required:
What we offer
Your Total Rewards package will include many components including:
How to Apply
To submit your application, please apply through our career portal https://ats.rippling.com/nanovation-careers/jobs. We would like to thank all applicants who apply. Please note that only those selected for an interview will be contacted.
All qualified applicants will receive consideration for employment without regard to race, colour, ancestry, place of origin, religion, marital status, family status, physical or mental disability, sex, sexual orientation, gender identity or expression, or age.
[]
Develops lipid nanoparticle nucleic acid therapies
NanoVation Therapeutics (NTx) develops and delivers nucleic acid therapies using lipid nanoparticle (LNP) platforms. Its LNP formulations are scalable and customizable to target specific tissues, payloads, and administration routes, enabling delivery of mRNA and other nucleic acids. The company differentiates itself with a next-generation LNP platform and a global network of NanoVation GENErators that foster collaboration and faster development, supported by partnerships and licensing. Its goal is to advance genetic medicines so more diseases become manageable or curable by improving delivery efficiency, safety, and durability.
Explore more opportunities at Nanovation Therapeutics